Naar homepage     
Chronische Cerebro-Spinale Veneuze Insufficiëntie
Aanmelden op het forum
Lees Voor (ReadSpeaker)    A-   A+
Over | Zoeken | Contact | Forum
PayPal, de veilige en complete manier van online betalen.

iDeal is onderdeel van de
Franz Schelling Stichting
meer informatie
Thursday, August 11, 2016 8:07 PM | CCSVI in Multiple Sclerosis Volg link
This headline is a lie---earlier treatment of MS w/interferon made NO DIFFERENCE in disability or MS progression. Bayer Pharmaceutical sponsored the study. "There was no difference between the two groups in the tests that measure overall disability or in MRI scans measuring the amount of damage caused by the disease."
Treating at the earliest sign of MS may offer long-term benefit
Starting medication for multiple sclerosis (MS) in people who show the beginning signs of the disease is associated with prolonging the time before the disease is definitively diagnosed, according to a long-term study published in the Aug. 10, 2016, online issue of Neurology®, the medical journal of...